DOW

ANALYST NOTE: DOW INC. (DOW) DATE: 2026-06-13 CURRENT PRICE: $31.73

1. Structural Readiness

State: Context-Only Conservative Entry: — Breakout Level: — Extension: — ATR Current: 4.5% (High)

Analysis:

2. Thesis Layer

Thesis Status: TACTICAL / SETUP-LED Secular Exposure: None Named

There is no named secular thesis attached to DOW Inc. as of this date. The name is being evaluated strictly on a tactical basis, driven by setup quality and immediate business fundamentals rather than a long-term macro narrative. Management expectations regarding the "Transform to Outperform" initiative provide the fundamental backdrop, but no specific secular theme (e.g., "Green Energy Transition" or "AI Infrastructure") is currently driving the conviction stack. The investment case rests entirely on the execution of the announced cost-saving programs and the cyclical recovery of the materials sector, rather than a structural secular shift.

3. Business Overview

Company: Dow Inc. Industry: Materials / Chemicals Business Model: Dow Inc. is a global leader in materials science, delivering diverse solutions for key industries including packaging, infrastructure, mobility, and consumer products. The company operates through three primary segments:

• Packaging & Specialty Plastics (P&SP): Produces foundational chemicals (ethylene, propylene, aromatics) and polymers (polyethylene, polyolefin elastomers).
• Industrial Intermediates & Infrastructure (I&I): Offers ethylene/propylene oxides, polyols, isocyanates, and polyurethane systems.
• Performance Materials & Coatings (PMC): Provides coatings, adhesives, silicones, and specialty materials.

Supporting Evidence (As of 2026-06-13):

• Revenue & EBITDA Guidance: In the Q1 2026 earnings transcript (2026-04-23), management stated an expectation for Q2 revenue of approximately $12 billion and EBITDA of $2 billion.
• Cost Transformation: The "Transform to Outperform" program, approved by the Board on January 26, 2026, is expected to deliver at least $2 billion in near-term EBITDA improvement. Management confirmed they are on track to deliver the remaining cost savings from a previously announced $1 billion program by the end of 2026.
• Operational Performance: Q1 2026 net sales were $9.8 billion (down 6% YoY), with operating EBITDA of $873 million. However, management noted "rapid, positive momentum" from pricing actions in every business and region.
• Volume Trends: P&SP product sales are heavily weighted toward resilient applications, with 80% going into packaging, consumer, and health/hygiene. Polyethylene volumes increased in all regions, supported by global growth in flexible food and specialty packaging.
• Supply Constraints: Management highlighted that roughly 20% of global oil capacity is offline, and approximately half of global ethylene and polyethylene supply is constrained or impacted, providing a tailwind for pricing power.
• Capital Projects: Construction of a world-scale polyethylene unit on the U.S. Gulf Coast was completed in 2025. Additionally, the integrated ethylene cracker in Alberta, Canada, is progressing toward net-zero Scope 1 and 2 emissions.
• Asset Optimization: A strategic review in 2025 led to a plan to shut down an ethylene cracker in Böhlen, Germany, by the end of 2027 to optimize the global asset footprint.

4. Archetype and Conviction

Archetype: Margin Inflector Rationale: DOW fits the Margin Inflector archetype. The company is executing a deliberate "Transform to Outperform" strategy focused on simplifying the operating model, reducing cost structures, and delivering faster growth. The evidence supports this:

• EBITDA Leverage: The commitment to $2 billion in near-term EBITDA improvement from the transformation program, combined with the completion of the $1 billion cost savings program, directly targets margin expansion.
• Pricing Power: Management reports "constructive impacts to operating rates" and "rapid, positive momentum" from pricing actions, indicating the ability to pass through costs or capture value in a constrained supply environment.
• Asset Rationalization: The planned shutdown of the Böhlen cracker (2027) and the completion of the Alberta net-zero complex signal a shift toward higher-value, more efficient assets.

Valuation & Conviction Context:

• Financial Spine: Forward consensus EPS for FY1 is $3.18 and FY2 is $2.56.
• Conviction Stack:
• *Thesis Strength:* Moderate. The "Transform to Outperform" is a clear, management-led plan, but it is tactical, not a secular growth story.
• *Evidence Quality:* High. Multiple primary sources (earnings transcripts, SEC filings) confirm the specific dollar amounts of savings and revenue guidance.
• *Structural Quality:* Mixed. While the business fundamentals are improving (EBITDA growth, volume increases in key regions), the credit rating outlook remains negative (S&P downgraded TDCC to BBB- with a negative outlook).
• *Setup Readiness:* Zero. The technical structure is absent.
• *Rerating Potential:* Dependent on the successful execution of the cost program and the realization of the $2 billion EBITDA target.

ATR Context:

5. Invalidations, Strengtheners, and Gaps

What Would Invalidate:

• Fundamental: Failure to deliver the $2 billion EBITDA improvement from the "Transform to Outperform" program, or a significant deterioration in the credit rating beyond the current negative outlook (e.g., further downgrades to BB+ or lower).
• Operational: A reversal in the "rapid, positive momentum" of pricing actions or a significant drop in volumes in the P&SP segment (currently 80% of sales).

What Would Strengthen:

• Fundamental: Confirmation that the Alberta net-zero complex is delivering the expected 2 million metric tons of organic growth ahead of schedule.
• Operational: Sustained volume growth in the U.S. & Canada (currently down 4%) and EMEAI (currently down 2%), matching the Latin America growth (up 9%).

Evidence Gaps:

• Technical Structure: There is no data on the current price action relative to moving averages or pivot points. The "Coil" is undefined.
• Debt Maturity Schedule: While credit ratings are mentioned, specific details on near-term debt maturities or refinancing needs are not provided in the evidence block.
• Feedstock Costs: While supply constraints are noted, the specific impact of feedstock costs on the margin inflector thesis is not quantified in the provided text.

PRIVATE ANALYST CALL

Judgment: Hold Confidence: medium Key evidence: Management guidance of $2B near-term EBITDA improvement from "Transform to Outperform"; 80% of P&SP sales in resilient applications; completion of U.S. Gulf Coast polyethylene unit in 2025. Key risks: Negative credit rating outlook (S&P BBB-); current revenue decline (-6% YoY in Q1); geopolitical tensions impacting Strait of Hormuz; lack of defined technical setup structure. Sizing hint: N/A (No setup defined; position sizing is irrelevant until structure forms). Expected path: Management expects to realize $2B in EBITDA improvement and complete the $1B cost savings program by year-end 2026; asset optimization continues with Böhlen shutdown planned for 2027. Expected horizon: 12-18 months for the "Transform to Outperform" program to fully materialize in earnings. Failure mode to watch: Failure to achieve the $2B EBITDA target or further credit rating downgrades indicating liquidity stress.